Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Baxter
Harvard Business School
UBS
Daiichi Sankyo
Argus Health

Generated: March 24, 2019

DrugPatentWatch Database Preview

FABRAZYME Drug Profile

« Back to Dashboard

Summary for Tradename: FABRAZYME
Pharmacology for FABRAZYME
Ingredient-typealpha-Glucosidases

US Patents for FABRAZYME

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genzyme FABRAZYME agalsidase beta VIAL; INTRAVENOUS 103979 002 2003-04-24 ➤ Try a Free Trial Orphazyme ApS (Kobenhavn N, DK) ➤ Try a Free Trial RX Orphan search
Genzyme FABRAZYME agalsidase beta VIAL; INTRAVENOUS 103979 002 2003-04-24 ➤ Try a Free Trial Protalix Ltd. (Carmiel, IL) ➤ Try a Free Trial RX Orphan search
Genzyme FABRAZYME agalsidase beta VIAL; INTRAVENOUS 103979 002 2003-04-24 ➤ Try a Free Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) ➤ Try a Free Trial RX Orphan search
Genzyme FABRAZYME agalsidase beta VIAL; INTRAVENOUS 103979 002 2003-04-24 ➤ Try a Free Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) ➤ Try a Free Trial RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for FABRAZYME

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
300452 Netherlands ➤ Try a Free Trial PRODUCT NAME: AGALSIDASE ALFA; REGISTRATION NO/DATE: EU/1/01/189/001 20010807
C01942189/01 Switzerland ➤ Try a Free Trial FORMER OWNER: MOUNT SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY, US
10C0032 France ➤ Try a Free Trial PRODUCT NAME: AGALSIDASE ALFA; NAT. REGISTRATION NO/DATE: EU/1/01/189/001-003 20010803; FIRST REGISTRATION: EU//1/01/189/001-003 20010803
20/2010 Austria ➤ Try a Free Trial PRODUCT NAME: AGALSIDASE ALPHA; REGISTRATION NO/DATE: EU/1/01/189/001 20010803
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Teva
Fish and Richardson
Baxter
Argus Health
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.